EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thiolated Hyaluronic Acid: A Gateway for Targeted Killing of Staphylococcus aureus on the Race for Surface Colonization

Mariana Blanco Massani iD, Susanne Meile iD, Annabelle Knoll, David Gintsburg iD, Ilaria Polidori iD, Anna Seybold iD, Débora C Coraça-Huber iD, Martin J Loessner iD, Gergely Kali iD, Mathias Schmelcher iD, Szczepan Zapotoczny iD, Andreas Bernkop-Schnürch iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202502890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Mariana Blanco Massani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Chemistry and Biomedicine (CCB), Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, I…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Staphylococcus aureus, Sulfhydryl Compounds, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyaluronic acid (HA) is degraded by Staphylococcal hyaluronate lyase (Hysa) and mammalian hyaluronidase (Hyal). Thiolated HA (HAMS) is used as a targeted gateway for Staphylococcus aureus killing while enhancing the previous M23 endolysin–polyphosphate (M23‐PP NPs) enzyme‐responsive nanoparticle formulation. Synthesis of HAMS and characterization for nuclear magnetic resonance, solubility, thiol content, pKa, and degradation by Hysa and Hyal are presented. Nanoparticles prepared via ionotropic gelation between M23‐PP NPs and either HAMS or HA yield M23‐PP/HAMS or M23‐PP/HA NPs, respectively. Their characterization includes size, zeta potential, morphology, release profiles, safety, targeted release, and efficacy. HAMS with a thiol content of 250.18 ± 90.32 µmol g −1 , solubility of 50.99 ± 0.02 mg mL −1 , exhibits pKa values of 3.2, 4.2, and 8.8. This thiolated polymer irreversibly inhibits Hyal activity, without affecting Hysa. M23‐PP/HAMS NPs (265 ± 47 nm, −25 mV) maintain their integrity for seven days at 37 °C, and HAMS coating prevents nonspecific degradation by Hyal, as confirmed by release studies. In a co‐culture ‘race for the surface’ experiment with MC3T3 osteoblasts and S. aureus ATCC 25923, M23‐PP/HAMS NPs produce 8‐log bacterial killing while promoting in vitro wound healing. These findings are pivotal to the development of new enzyme‐responsive excipients switchable by S. aureus .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidStaphylococcus aureusSulfhydryl CompoundsAnti-Bacterial AgentsAnimalsMiceNanoparticlesHyaluronoglucosaminidasePolysaccharide-LyasesPolyphosphates

Stichwörter der Autor:innen

Staphylococcus aureusenzyme‐responsivephage endolysinstargeted drug deliverythiolated hyaluronic acid

Substanzen

Hyaluronic AcidHyaluronoglucosaminidasehyaluronate lyaseSulfhydryl CompoundsPolysaccharide-LyasesAnti-Bacterial AgentsPolyphosphates

Autor:innen und Institutionen

  • Centre for Chemistry and Biomedicine (CCB), Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80/82, Innsbruck, 6020, Austria.
  • Institute of Food, Nutrition and Health, ETH Zürich, Schmelzbergstrasse 7, Zürich, 8092, Switzerland.
  • Department of Zoology, University of Innsbruck, Innsbruck, 6020, Austria.
  • Biofilm Lab, Experimental Orthopedics, University Hospital for Orthopaedics and Traumatology, Medical University Innsbruck, Müllerstrasse 44, 1. Floor, Innsbruck, 6020, Austria.
  • Faculty of Chemistry, Nanoengineering of Functional Polymeric Materials Group, Jagiellonian University, Gronostajowa 2, Krakow (Krakow-Podgorze), 30-387, Poland.

ORCID-Profile: Mariana Blanco Massani, Susanne Meile, David Gintsburg, Ilaria Polidori, Anna Seybold, Débora C Coraça-Huber, Martin J Loessner, Gergely Kali, Mathias Schmelcher, Szczepan Zapotoczny, Andreas Bernkop-Schnürch

Förderung

  • European Union's Horizon 2020

Zitieren

APA

Massani, M. B., Meile, S., Knoll, A., Gintsburg, D., Polidori, I., Seybold, A., Coraça-Huber, D. C., Loessner, M. J., Kali, G., Schmelcher, M., Zapotoczny, S., & Bernkop-Schnürch, A. (2026). Thiolated Hyaluronic Acid: A Gateway for Targeted Killing of Staphylococcus aureus on the Race for Surface Colonization. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502890

Vancouver

Massani MB, Meile S, Knoll A, Gintsburg D, Polidori I, Seybold A, et al. Thiolated Hyaluronic Acid: A Gateway for Targeted Killing of Staphylococcus aureus on the Race for Surface Colonization. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502890

BibTeX
@article{Massani2026,
  author = {Massani, Mariana Blanco and Meile, Susanne and Knoll, Annabelle and Gintsburg, David and Polidori, Ilaria and Seybold, Anna and Coraça-Huber, Débora C and Loessner, Martin J and Kali, Gergely and Schmelcher, Mathias and Zapotoczny, Szczepan and Bernkop-Schnürch, Andreas},
  title = {Thiolated Hyaluronic Acid: A Gateway for Targeted Killing of Staphylococcus aureus on the Race for Surface Colonization},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202502890}
}
Kostenlos starten →